GLSI
Greenwich Lifesciences Inc
15.10$
-1.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | – | – | – | 100.0% | – | – | – | 100.0% | – | 100.0% | |
| – | – | 16.7% | – | – | – | 25.0% | – | – | – | 50.0% | – | – | |
| – | – | -16.7% | – | – | – | -25.0% | – | – | – | 50.0% | – | – | |
| – | – | 40,504.1% | – | – | – | 62,877.9% | – | – | – | 146,362.1% | – | 558,674.8% | |
| – | – | 6,325.0% | – | – | – | 18,859.6% | – | – | – | 14,564.1% | – | 55,912.9% | |
| – | – | 46,812.4% | – | – | – | 76,629.2% | – | – | – | 160,926.2% | – | 614,587.7% | |
| – | – | -46,829.1% | – | – | – | -76,654.2% | – | – | – | -160,926.2% | – | -614,587.7% | |
| – | – | 2,144.3% | – | – | – | 6,174.1% | – | – | – | – | – | – | |
| – | – | -45,647.7% | – | – | – | -75,990.6% | – | – | – | -158,997.7% | – | -609,342.0% | |
| – | – | -0.1% | – | – | – | 70,268.7% | – | – | – | – | – | – | |
| – | – | -45,647.7% | – | – | – | -75,990.6% | – | – | – | -158,997.7% | – | -609,342.0% | |
| – | – | -45,631.1% | – | – | – | -75,965.6% | – | – | – | -158,997.7% | – | -609,917.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.